Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
L/6589/Add.2 Addendum couvert du document L/6589/Add.1. La traduction non officielle de cette en el documents L/6589/Add.l. La t
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012
PDF) Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure | SpringerLink
La libre fixation des prix des médicaments financés dans les groupes homogènes de séjour hospitalier : une exception au régime des prix administrés des médicaments à conserver ? | Cairn.info
Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France”
Full article: A comparative public health and budget impact analysis of pneumococcal vaccines: The French case
Nouvelle indemnisation transparente pour les médicaments soumis à ordonnance | Communauté d'achat HSK SA
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Association des POIC - La base AMELI a enfin été mise à jour concernant la retrocession de la Trimebutine injectable. Aucune pharmacie centrale ne peut, désormais, refuser de la délivrer (sur prescription
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France | PLOS ONE
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study - Clinical Gastroenterology and Hepatology
Patient access to orphan drugs in France | Orphanet Journal of Rare Diseases | Full Text
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
PDF) Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: Results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
PDF) The economic burden of urinary tract infections in women visiting general practices in France: A cross-sectional survey
utilisation des médicaments dans les maisons de soins - KCE
8 remèdes au prix élevé des médicaments | Paperjam News
Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
PowerPoint 簡報
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
Modèle tarifaire équitable | Zur Rose
Réforme de l'accès dérogatoire aux médicaments (MAJ 24/04/23) - OMEDIT Ile de France
Supplementary materials Methods Calculation of costs and HCRU A cost of €24.13, which included official tariffs and surcharges
